{"database": "press", "table": "releases", "rows": [["https://mcbath.house.gov/press-releases?ID=115B5E93-F59E-4624-8AF5-F94F7E703BA1", "Representatives McBath, Craig, Landsman, Horsford, Schrier Introduce Bill to Extend $35 Per Month Insulin Cost Cap", "2025-11-21", "2025", "2025-11", "Democrat", "House", "GA", "Lucy McBath", "M001208", "mcbath.house.gov", "mcbath", "https://mcbath.house.gov/press-releases", "scraper", "Washington, DC\u2014During Diabetes Month, Representative Lucy McBath (GA-06) joined Angie Craig (MN-02), Greg Landsman (OH-01), Steven Horsford (NV-04), and Kim Schrier (WA-08) to introduce the Affordable Insulin Now Act to help Americans with private insurance afford insulin.\n\nThe bill would extend the $35 insulin cap for seniors on Medicare\u2014also led by McBath\u2014that was passed into law through the Inflation Reduction Act (IRA). As the Education and Workforce Committee lead of this legislation, McBath continues to stand up for America\u2019s families so they can live full, healthy lives.\n\n\u201cNo person should be forced to skip or ration medication because they cannot afford it,\u201d said Rep. McBath. \u201cWith health care affordability concerns more relevant than ever, we must work with urgency to address some of the most common medical expenses that strain American household budgets. I am grateful to my colleagues for our continued work to drive down the cost of insulin for all who need it.\u201d\n\n\u201cFor years, pharmaceutical companies have raked in record profits by price gouging consumers \u2013 forcing everyday Minnesotans to make the impossible choice between picking up lifesaving prescriptions and putting food on the table,\u201d said Rep. Craig. \u201cWe have seen over time that the pressure we\u2019ve put on Big Pharma is working, and this bill is the next step in our fight to make insulin affordable for every American who needs it.\u201d\n\n\u201cInsulin is a lifesaving medication, but every day in this country people are forced to make drastic financial decisions just to afford it,\u201d said Rep. Landsman. \u201cAmericans deserve affordable healthcare, and we have to finish the job of capping insulin costs, so no one has to struggle to survive.\u201d\n\n\u201cHigh insulin prices can cost someone their life,\u201d said Rep. Horsford. \u201cI\u2019m proud to partner with Representatives Craig, Landsman, McBath, and Schrier to make sure this critical medication is accessible and affordable to all who need it. State lawmakers in Nevada passed a bill ensuring affordable insulin prices earlier this summer, and the bill we\u2019re introducing today will expand that effort nationally. As tens of millions of Americans stand to lose health care coverage from Republican \u2018Big Beautiful\u2019 bill cuts and their refusal to extend health care tax credits, there has never been a more important time to pass the Affordable Insulin Now Act into law.\u201d\n\n\u201cAs a doctor and someone who has lived with type 1 diabetes for over four decades, I have seen how the price of insulin has skyrocketed over the years and know firsthand the pressure that these price hikes have put on patients,\u201d said Rep. Schrier, M.D. \u201cUnaffordable insulin has even forced some to ration or go completely without the medication their lives depend on, with deadly consequences. I was proud to work with my colleagues to cap the cost of insulin for those on Medicare, and I am thrilled to continue our work to lower the price of this lifesaving medication for millions more.\u201d\n\nThe bill is also endorsed by Protect Our Care, the American Diabetes Association, Social Security Works and Breakthrough T1D.\n\n\u201cNo one should go bankrupt buying the insulin that keeps them alive,\u201d said Protect Our Care Director of Policy Programs Vaishu Jawahar. \u201cBy capping what privately insured Americans pay out-of-pocket for insulin, the Affordable Insulin Now Act extends a critical lifeline to diabetics and their families. While Donald Trump and Republicans in Congress continue driving up drug costs and padding drug company profits, this legislation will save lives and make health care more affordable for everyday Americans.\u201d\n\n\u201cThe ADA supports the Affordable Insulin Now Act, which would limit out-of-pocket cost for insulin at $35 a month for individuals with private health insurance,\u201d said Catherine Ferguson, Vice President for Federal Advocacy, the American Diabetes Association. \u201cThis bill is a critical step to ensure people with diabetes who need insulin to live can afford it.\u201d\n\n\u201cNo one should suffer, go bankrupt, or die because big pharma billionaires are price gouging the insulin they need to survive,\u201d said Alex Lawson, Executive Director, Social Security Works. \u201cThis bill is a critical step towards ensuring that insulin is affordable and protecting Americans from the criminally high prices that pharmaceutical companies charge.\u201d", 1, "2026-03-30T01:40:41Z", "2026-04-06T19:52:45Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://mcbath.house.gov/press-releases?ID=115B5E93-F59E-4624-8AF5-F94F7E703BA1"], "units": {}, "query_ms": 0.6583749782294035, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}